Study of early stages of amyloid Aβ13-23 formation using molecular dynamics simulation in implicit environments

β-amyloid aggregation and formation of senile plaques is one of the hallmarks of Alzheimer's disease (AD). It leads to degeneration of neurons and decline of cognitive functions. The most aggregative and toxic form of β-amyloid is Aβ1-42 but in experiments, the shorter forms able to form aggregates are also used. The early stages of amyloid formation are of special interest due to the influence of this peptide on progression of AD. Here, we employed nine helices of undecapeptide Aβ13-23 and studied progress of amyloid formation using 500ns molecular dynamics simulation and implicit membrane environment. The small β-sheets emerged very early during simulation as separated two-strand structures and a presence of the membrane facilitated this process. Later, the larger β-sheets were formed. However, the ninth helix which did not form paired structure stayed unchanged till the end of MD simulation. Paired helix-helix interactions seemed to be a driving force of β-sheet formation at early stages of amyloid formation. Contrary, the specific interactions between α-helix and β-sheet can be very stable and be stabilized by the membrane.

[1]  M. Berkowitz,et al.  Structure of the amyloid-beta (1-42) monomer absorbed to model phospholipid bilayers: a molecular dynamics study. , 2009, The journal of physical chemistry. B.

[2]  Thomas L. Williams,et al.  Membrane and surface interactions of Alzheimer’s Aβ peptide – insights into the mechanism of cytotoxicity , 2011, The FEBS journal.

[3]  Yinan Lin,et al.  Structure, orientation, and surface interaction of Alzheimer amyloid-β peptides on the graphite. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[4]  R. Nussinov,et al.  Modeling the Alzheimer Abeta17-42 fibril architecture: tight intermolecular sheet-sheet association and intramolecular hydrated cavities. , 2007, Biophysical journal.

[5]  Anselm H. C. Horn,et al.  Rational design of β-sheet ligands against Aβ42-induced toxicity. , 2011, Journal of the American Chemical Society.

[6]  A Caflisch,et al.  A molecular dynamics approach to the structural characterization of amyloid aggregation. , 2006, Journal of molecular biology.

[7]  H. Shao,et al.  Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. , 1999, Journal of molecular biology.

[8]  F. Stellato,et al.  Zn induced structural aggregation patterns of β-amyloid peptides by first-principle simulations and XAS measurements. , 2012, Metallomics : integrated biometal science.

[9]  Sarah Rauscher,et al.  Molecular mechanism of β‐sheet self‐organization at water‐hydrophobic interfaces , 2011, Proteins.

[10]  M. Sathya,et al.  BACE1 in Alzheimer's disease. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[11]  V. Andrisano,et al.  Amyloid β-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer's disease process and treatment. , 2012, ACS chemical neuroscience.

[12]  R. Tycko Solid-state NMR studies of amyloid fibril structure. , 2011, Annual review of physical chemistry.

[13]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[14]  Charles D. Schwieters,et al.  Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue , 2013, Cell.

[15]  F. Stellato,et al.  Metal binding in amyloid β-peptides shows intra- and inter-peptide coordination modes , 2006, European Biophysics Journal.

[16]  B. Urbanc,et al.  Insights into Aβ aggregation: a molecular dynamics perspective. , 2013, Current topics in medicinal chemistry.

[17]  P. Wong,et al.  Amyloid precursor protein processing and Alzheimer's disease. , 2011, Annual review of neuroscience.

[18]  Themis Lazaridis,et al.  Implicit solvent simulations of peptide interactions with anionic lipid membranes , 2004, Proteins.

[19]  Jie Zheng,et al.  Molecular dynamics simulations of low-ordered alzheimer β-amyloid oligomers from dimer to hexamer on self-assembled monolayers. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[20]  A. Bonvin,et al.  The α‐to‐β Conformational Transition of Alzheimer's Aβ‐(1–42) Peptide in Aqueous Media is Reversible: A Step by Step Conformational Analysis Suggests the Location of β Conformation Seeding , 2006 .

[21]  S. Saxena,et al.  Zn(II) ions substantially perturb Cu(II) ion coordination in amyloid-β at physiological pH. , 2013, The journal of physical chemistry. B.

[22]  Ehud Gazit,et al.  A possible role for π‐stacking in the self‐assembly of amyloid fibrils , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Michele Vendruscolo,et al.  Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism , 2013, Proceedings of the National Academy of Sciences.

[24]  Kenjiro Ono,et al.  Structure–neurotoxicity relationships of amyloid β-protein oligomers , 2009, Proceedings of the National Academy of Sciences.

[25]  J. Scheiber,et al.  Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases. , 2010, Bioorganic & medicinal chemistry.

[26]  E. Gazit Mechanisms of amyloid fibril self‐assembly and inhibition , 2005, The FEBS journal.

[27]  Justin A. Lemkul,et al.  Aggregation of Alzheimer's amyloid β-peptide in biological membranes: a molecular dynamics study. , 2013, Biochemistry.

[28]  T. Lazaridis Effective energy function for proteins in lipid membranes , 2003, Proteins.

[29]  G. Evin,et al.  β‐Site APP‐cleaving enzyme 1 trafficking and Alzheimer’s disease pathogenesis , 2012, Journal of neurochemistry.

[30]  G. Logroscino,et al.  Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation. , 2011, Current medicinal chemistry.

[31]  C. Schwieters,et al.  Molecular Structure of beta-Amyloid Fibrils in Alzheimer's Disease Brain Tissue. , 2013 .

[32]  Brigita Urbanc,et al.  Computer Simulations of Alzheimers Amyloid β-Protein Folding and Assembly , 2006 .

[33]  Chewook Lee,et al.  Charactering Amyloid-Beta Protein Misfolding from Molecular Dynamics Simulation with Explicit Water , 2010 .

[34]  V. Lee,et al.  Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles* , 2011, The Journal of Biological Chemistry.

[35]  T. Härd,et al.  Amyloid-β Protofibrils: Size, Morphology and Synaptotoxicity of an Engineered Mimic , 2013, PloS one.

[36]  U. Holzgrabe,et al.  Design, Synthesis and Evaluation of Novel 2‐(Aminoalkyl)‐isoindoline‐1,3‐dione Derivatives as Dual‐Binding Site Acetylcholinesterase Inhibitors , 2012, Archiv der Pharmazie.

[37]  M. Berkowitz,et al.  Interaction between amyloid-beta (1-42) peptide and phospholipid bilayers: a molecular dynamics study. , 2009, Biophysical journal.

[38]  Jingdai Wang,et al.  Comparative molecular dynamics study of Abeta adsorption on the self-assembled monolayers. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[39]  D. Holtzman,et al.  Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement. , 2012, Current opinion in neurology.

[40]  Ruth Nussinov,et al.  Zinc ions promote Alzheimer Aβ aggregation via population shift of polymorphic states , 2010, Proceedings of the National Academy of Sciences.

[41]  A. D'Ursi,et al.  Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. , 2002, European journal of biochemistry.

[42]  Lei Gu,et al.  Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils , 2013, Journal of neurochemistry.

[43]  S. DeKosky,et al.  Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress. , 2013, Annual review of medicine.

[44]  M. Kirkitadze,et al.  Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. , 2001, Journal of molecular biology.

[45]  B. Allinquant,et al.  Functions of Aβ, sAPPα and sAPPβ : similarities and differences , 2012, Journal of neurochemistry.

[46]  U. Holzgrabe,et al.  1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-β aggregation crossing the blood-brain barrier. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[47]  C. Robinson,et al.  Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. , 2009, Nature chemistry.

[48]  R. Chiaraluce,et al.  Computational and Experimental Studies on β-Sheet Breakers Targeting Aβ1–40 Fibrils , 2014, The Journal of Biological Chemistry.

[49]  U. Holzgrabe,et al.  Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.